Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).
UK’s asylum process takes a toll on the health and wellbeing of people seeking sanctuary
The UK’s asylum process is damaging to the health and wellbeing of people seeking sanctuary – according to a new study from the University of East